Cargando…
Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer
Olfactomedin 4 (OLFM4) is a secreted glycoprotein predominantly expressed in bone marrow and gastrointestinal tissues. Aberrant expression of OLFM4 has been shown in several cancers. However, the clinical significance hereof is currently controversial. OLFM4 has been proposed as a candidate biomarke...
Autores principales: | Clemmensen, Stine N., Glenthøj, Anders J., Heebøll, Sara, Nielsen, Hans Jørgen, Koch, Claus, Borregaard, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687705/ https://www.ncbi.nlm.nih.gov/pubmed/26416558 http://dx.doi.org/10.1111/jcmm.12679 |
Ejemplares similares
-
New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022) -
Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma
por: Suzuki, Lucia, et al.
Publicado: (2019) -
Significance of differential expression of OLFM4 in the development of endometrial adenocarcinoma
por: Huang, Di, et al.
Publicado: (2022) -
Robust Cre-Mediated Recombination in Small Intestinal Stem Cells Utilizing the Olfm4 Locus
por: Schuijers, Jurian, et al.
Publicado: (2014) -
OLFM4 Inhibits Epithelial–Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells
por: Li, Juan, et al.
Publicado: (2019)